2-({(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione 446292-08-6 98%
Price | Get Latest Price | |||
Packge | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-12
Product Details
- Product Name2-({(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
- CAS No.446292-08-6
- EINECS No.610-201-0
- MFC22H19N3O6
- MW421.4
- AppearanceSolidWhite to Off-White
- Boiling point 702.9±55.0 °C(Predicted)
- density 1.465±0.06 g/cm3(Predicted)
- storage temp. Inert atmosphere,Room Temperature
- Melting point 213-215°C
- Water Solubility 12mg/L at 20℃
Company Profile Introduction
Cohance Lifesciences (formerly Zandu Chemicals Ltd) are one of the fastest growing Pharmaceutical companies in India that combines the power of Science & Technology together. Established in 1991, we are headquartered in Mumbai and have a state-of- the- art US FDA successfully inspected facility with a capacity of 214 KL along with strong research & development capabilities strategically located in the industrial park of Ankleshwar, Gujarat.
We are a 100% EOU (Export Oriented Unit) engaged in manufacturing and exports of advanced drug intermediates and Active Pharma Ingredients (APIs). We are a specialized Pharma company focusing on the niche therapeutic areas of CNS, ARVs and Controlled substances having tremendous future growth potential. By virtue of this niche focus we have registered an impressive growth over the years.
Our strategy going forward is to further consolidate our pre-eminent position in the high growth therapeutic areas by expanding our capacity for present advanced intermediates and moving up the value chain by expanding capacity for APIs and diversifying product portfolio into the other high growth therapeutic areas.
We are a US FDA, KFDA, WHO-GMP and Japanese MOH accredited company having certifications of ISO 9001, ISO 14001 and OHSAS 18001. We enjoy the CRISIL rating of A(-) and have SAP system in place.
Supplier other products
Recommended supplier
-
VIP1年
- LOBERAN PHARMA
- 446292-08-6 (S)-2-{2-Oxo-3-[4-(3-oxo-morpholin-4-yl)-phenyl]-oxazolidin-5-ylmethyl}-isoindole-1,3-dione 99
- Inquiry
- 2024-11-14
-
VIP1年
- Clickchem Research LLP
- RIVAROXABAN EP IMP G 90 % Above
- Inquiry
- 2024-04-30
-
VIP1年
- Actis Generics Pvt Ltd
- 446292-08-6 98%
- Inquiry
- 2024-03-20
-
VIP1年
- Aspen Biopharma Labs Pvt Ltd
- 446292-08-6 2-({(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione 98%
- Inquiry
- 2024-03-16
-
VIP1年
- Cubane Pharmaceuticals LLP
- 2-({(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione 99%
- Inquiry
- 2024-02-08
-
VIP1年
- Acute Research
- 446292-08-6 98%
- Inquiry
- 2024-01-29
-
VIP1年
- Prash Intermediates
- 446292-08-6 2-({(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione 98%
- Inquiry
- 2024-01-19
-
VIP1年
- Anlon Healthcare Pvt Ltd
- 2-({(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione 99%
- Inquiry
- 2024-01-11
- Since:2020-01-01
- Address: "215 Atrium, C Wing, 8th Floor, 819-821,_x000D_ Andheri-Kurla Road, Chakala, Andheri (E), Mumbai, M